Post-approval studies (Phase 4)Study completedNCT00681187What this trial is testingSomatuline Autogel Preference and Health Economy StudyWho this might be right forNeuroendocrine Tumour With Carcinoid Symptoms Ipsen 26
Testing effectiveness (Phase 2)WithdrawnNCT04713202What this trial is testingProspective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylWho this might be right forNeuroendocrine TumorsCarcinoid SyndromeDiarrhea Chandrikha Chandrasekhara
Testing effectiveness (Phase 2)Study completedNCT01253161What this trial is testingStudy of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)Who this might be right forNeuroendocrine TumorsCarcinoid Tumors H. Lee Moffitt Cancer Center and Research Institute 29
Not applicableEnded earlyNCT00730483What this trial is testingDoxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorMetastatic Cancer Yale University 13
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT06472388What this trial is testingEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more AC Camargo Cancer Center 100
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT03722511What this trial is testingEvaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETsWho this might be right forNeuroendocrine TumorsCarcinoid Tumor of GI SystemDiarrhea+1 more Lowell Anthony, MD 10
Large-scale testing (Phase 3)Study completedNCT00690430What this trial is testingEfficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid DiseaseWho this might be right forSymptomatic Refractory Resistant Carcinoid Disease Novartis Pharmaceuticals 186
Testing effectiveness (Phase 2)Study completedNCT00050349What this trial is testingEPO906 in Carcinoid and Other Neuroendocrine TumorsWho this might be right forCarcinoidNeuroendocrine Tumors Novartis Pharmaceuticals 33
Large-scale testing (Phase 3)Ended earlyNCT00092287What this trial is testingComparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid SyndromeWho this might be right forMalignant Carcinoid Syndrome Ipsen 4
Testing effectiveness (Phase 2)Ended earlyNCT01886287What this trial is testingP:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid SyndromeWho this might be right forNeuroendocrine Carcinoma H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT00781911What this trial is testingCixutumumab (IMC-A12) in Islet Cell CancerWho this might be right forCarcinomaNeuroendocrine Tumors Eli Lilly and Company 43
Testing effectiveness (Phase 2)UnknownNCT01731925What this trial is testingSunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid TumorsWho this might be right forCarcinoid Tumors GERCOR - Multidisciplinary Oncology Cooperative Group 44
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Not applicableUnknownNCT00454376What this trial is testingDisease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more National Cancer Institute (NCI) 408
Testing effectiveness (Phase 2)UnknownNCT00637637What this trial is testingExternal-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesWho this might be right forCancer Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Who this might be right forAdvanced CancerAnal CarcinomaAnal Cancer+22 more Merck Sharp & Dohme LLC 1,609
Testing effectiveness (Phase 2)WithdrawnNCT04276597What this trial is testingPhase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.Who this might be right forPulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more Excel Diagnostics and Nuclear Oncology Center